Dark

Check out our Dark Pool Levels

EPI
WisdomTree India Earnings Fund ETF
stock NYSE ETF

At Close

Aug 7, 2026 3:59:50 PM EDT

43.67USD+0.622%(+0.27)210,227

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-43.40)0

After-hours

Aug 7, 2026 4:10:30 PM EDT

43.68USD+0.023%(+0.01)971

OverviewOptionsHistoricalExchangesShortsNews

Mar 30, 2021

11:16AM EDT US-China Tension Can Spur India's Global Tech Hub Aspirations: Bloomberg Benzinga

Feb 25, 2021

06:34PM EST ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of PR Newswire

Jan 13, 2021

07:23AM EST ESSA Pharma Enters Clinical Collaboration And Supply Agreement With Janssen Research & Development, LLC RTTNews

07:19AM EST ESSA, Janssen To Evaluate EPI-7386 Combination For Patients With Metastatic Castration-Resistant Prostate Cancer RTTNews

07:02AM EST ESSA Pharma Enters Clinical Collaboration With Janssen To Evaluate EPI-7386 Combination For Patients With MCRPC RTTNews

07:01AM EST ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 PR Newswire

Dec 15, 2020

05:01PM EST ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal PR Newswire

Nov 25, 2020

07:01AM EST ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference PR Newswire

Oct 26, 2020

05:01PM EDT ESSA Pharma Inc. Announces Delisting from the TSX-V PR Newswire

Oct 24, 2020

07:19PM EDT ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR PR Newswire

Oct 19, 2020

07:01AM EDT ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming PR Newswire

Sep 21, 2020

07:01AM EDT ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & PR Newswire

Sep 17, 2020

05:06PM EDT ESSA Pharma Announces the Presentation of Additional Preclinical Data for PR Newswire

Sep 14, 2020

07:16AM EDT ESSA Pharma: FDA Grants Fast Track Designation To EPI-7386 For Metastatic Castration-Resistant Prostate Cancer RTTNews

07:01AM EDT ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for PR Newswire

Aug 6, 2020

08:53PM EDT ESSA Pharma Q3 Net Loss Of $4.9 Mln Or $0.24/shr Vs. Net Loss Of $3.3 Mln Or $0.52/shr Prior Year RTTNews

08:00PM EDT ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal PR Newswire

Jul 31, 2020

10:18AM EDT ESSA Pharma Completes Public Offering For Aggregate Gross Proceeds Of US$48.99 Mln RTTNews

10:17AM EDT ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of PR Newswire

Jul 29, 2020

09:06AM EDT IIROC Trading Resumption - EPI PR Newswire

Jul 28, 2020

09:51PM EDT ESSA Pharma Announces Pricing Of Underwritten Public Offering Of 7.10 Mln Shares At US$6.00/shr RTTNews

09:19PM EDT ESSA Pharma Announces Pricing of Public Offering of Common Shares PR Newswire

04:02PM EDT IIROC Trading Halt - EPI PR Newswire

04:02PM EDT ESSA Pharma Announces Proposed Public Offering of Common Shares PR Newswire

Jul 15, 2020

07:09AM EDT ESSA Pharma Announces First Patient Dosed In A Phase 1 Clinical Trial Of EPI-7386 For MCRPC RTTNews

07:01AM EDT ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of PR Newswire

Share